Alaunos Therapeutics Inc. (NASDAQ: TCRT)
$0.65
+0.0010 ( +0.15% ) 44.7K
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.